In ₹ Crore except Per Share Latest Annual	MEDICAMEQ FY26	MEDICO FY26	AAREYDRUGS FY26	NECLIFE FY26	Peer Average
Valuation — at last close
P/E	35.21×	◆ 12.16×	77.73×	—	44.95× -22%
P/B	1.25×	2.11×	2.04×	◆ 0.35×	1.50× -17%
EV/EBITDA	18.31×	10.26×	49.64×	◆ -1.25×	19.55× -6%
Market Cap	₹345 Cr	₹160 Cr	₹307 Cr	₹201 Cr	₹223 Cr +55%
Growth
Revenue CAGR 3Y	11.97%	13.69%	◆ 96.26%	-81.73%	9.41% +27%
Revenue CAGR 5Y	—	—	—	-64.04%	-64.04%
Net Income CAGR 3Y	-12.71%	21.89%	◆ 100.20%	—	61.05% -121%
Revenue YoY (latest Q)	11.27%	◆ 81.43%	-56.34%	-99.99%	-24.97% +145%
Net Income YoY (latest Q)	15.35%	38.49%	-25.36%	◆ 75.65%	29.59% -48%
Profitability
EBITDA Margin	◆ 9.90%	8.25%	1.52%	—	4.88% +103%
Net Income Margin	4.95%	◆ 6.35%	0.84%	-3152.45%	-1048.42% +100%
Return on Common Equity	3.95%	◆ 19.04%	2.75%	-38.08%	-5.43% +173%
Return on Capital Employed	4.92%	◆ 20.13%	2.94%	-7.53%	5.18% -5%
Return on Assets	2.93%	◆ 9.61%	1.48%	-21.95%	-3.62% +181%
Credit & Quality
Total Debt/Equity	0.17×	0.25×	0.33×	◆ 0.00×	0.19× -12%
Interest Coverage	3.54×	◆ 7.71×	0.86×	-1.69×	2.29× +54%
Scale — latest FY
Revenue / Total Income	₹198 Cr	₹206 Cr	₹472 Cr	₹0 Cr	₹226 Cr -13%
Net Income	₹9.8 Cr	₹13.1 Cr	₹4 Cr	−₹293 Cr	−₹91.9 Cr +111%
Total Assets	₹372 Cr	₹153 Cr	₹297 Cr	₹622 Cr	₹357 Cr +4%
EPS	₹7.22	₹1.58	₹1.39	₹-13.4	₹-3.48 +308%
Book Value per Share	₹203.17	₹9.09	₹52.86	₹29.97	₹30.64 +563%

◆ best value in the comp set per metric · Δ = subject vs average of the other companies.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.